Newsroom

MUMBAI, India e JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (insieme alle sue aziende controllate e/o associate, “Sun Pharma”) e Organon & Co. (NYSE: OGN) (“Organon”) oggi ha annunciato di aver stretto un accordo definitivo che prevede l'acquisto da parte di Sun Pharma di tutte le azioni rimaste di Organon al costo di 14,00 dollari l'una in una transazione in contanti basata su una valutazione a...

MUMBAI, India & JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (samen met zijn dochterondernemingen en/of geassocieerde ondernemingen, “Sun Pharma”) en Organon & Co. (NYSE: OGN) (“Organon”) hebben vandaag bekendgemaakt dat zij een definitieve overeenkomst hebben gesloten, waarbij Sun Pharma alle uitstaande aandelen van Organon zal verwerven voor US$ 14,00 dollar per aandeel. De transactie vindt vol...

WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Summer Road LLC (“Summer Road” or “we”), the beneficial owner of approximately 3% of the outstanding shares of Class A common stock of Ingles Markets, Incorporated (NASDAQ: IMKTA) (“Ingles” or the “Company”), today issued the following open letter to shareholders seeking their support for the election of Rory A. Held to Ingles’ Board of Directors (the “Board”) at the 2026 Annual Meeting of Shareholders. *** Fellow Shareholders, We greatly appreciate the d...

WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or “Easterly”), a fully integrated real estate investment trust (“REIT”) focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government and its adjacent partners, today announced its results of operations for the quarter ended March 31, 2026. Highlights for the Quarter Ended March 31, 2026: Net income of $1.4 million, or $0.03 per share on...

印度孟买、新泽西州泽西市--(BUSINESS WIRE)--(美国商业资讯)-- Sun Pharmaceutical Industries Limited（Reuters：SUN.BO，Bloomberg：SUNP IN，NSE：SUNPHARMA，BSE：524715） （连同其子公司和/或关联公司，统称“Sun Pharma”）与Organon & Co.（NYSE：OGN）（“Organon”）今日宣布，双方已签署最终协议，根据该协议，Sun Pharma将以每股14.00美元的全现金交易方式收购Organon所有流通股，此次交易的企业估值为117.5亿美元。 Organon是一家跨国医疗保健公司，于2021年从Merck分拆成立，在美国和加拿大以外地区称为MSD。Organon在医疗保健专业人员、患者、监管机构及其他利益相关者中拥有深厚的信任基础和强大的品牌价值。作为女性健康领域的全球领导者，公司的产品组合涵盖女性健康及普药（包括生物类似药）领域的70余种产品，已在全球140个国家上市，其中美国、欧洲、中国、加拿大和巴西是其最大的市场。这一全球业务布局依托于分布在欧...

Mumbai, Índia e Jersey City, Nova Jersey--(BUSINESS WIRE)--A Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (em conjunto com suas subsidiárias e/ou empresas associadas, “Sun Pharma”) e a Organon & Co. (NYSE: OGN) (“Organon”) anunciaram hoje a assinatura de um acordo definitivo pelo qual a Sun Pharma adquirirá todas as ações em circulação da Organon por US$ 14,00 por ação, em uma transação totalmente em dinheiro, com uma avaliação da...

印度孟買與美國紐澤西州澤西市--(BUSINESS WIRE)--(美國商業資訊)-- Sun Pharmaceutical Industries Limited (路透社代碼：SUN.BO，彭博代碼：SUNP IN，NSE：SUNPHARMA，BSE：524715)(連同其子公司及/或關係企業，簡稱「Sun Pharma」)與Organon & Co. (NYSE：OGN)(簡稱「Organon」)今日宣布，雙方已簽訂最終協議，根據該協議，Sun Pharma將以每股14.00美元的現金交易，收購Organon所有已發行股份，此交易對Organon的企業估值為117.5億美元。 Organon是一家全球醫療保健公司，於2021年從Merck(在美國與加拿大以外地區稱為MSD)分拆成立。Organon在醫療保健專業人員、病患、監管機構及其他利害關係人之間，擁有深厚的信任傳承與強大的品牌資產。作為女性健康領域的全球領導者，該公司的產品組合包含超過70種產品，涵蓋女性健康與一般藥物(包括生物相似藥)，在140個國家/地區商業化銷售，其中美國、歐洲、中國、加拿大和巴西是其最大的市場。...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION   (a) Full name of discloser: Massachusetts Financial Services Company (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficia...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 24.04.2026 FEUD IE00BF2FL590  367,749.00 EUR  20,211,140.88   54.959  ...

KYOTO, Japan--(BUSINESS WIRE)--Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) is gestart met de massaproductie van haar MRMS166R en MRMS168R AMR-sensoren (Anisotropic MagnetoResistance = anisotrope magneetweerstand) voor gezondheidszorg, wearable en IoT-apparaten. De MRMS166R is de eerste AMR-sensor die een gemiddeld stroomverbruik van 20 nA combineert met de werking van een 1,2 V voeding, waardoor langere levensduur van een batterij in systemen gevoed met een knoopcel mogeli...